EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumoursBehzad M. Toosi(University of Saskatchewan), Andrew Freywald(University of Saskatchewan)OncogeneApril 25, 201810.1038/s41388-018-0228-xCited by 42SaveCiteExport RISWatch citationsRelated PapersEphB Receptors Trigger Akt Activation and Suppress Fas Receptor-Induced Apoptosis in Malignant T Lymphocytes|The Journal of Immunology|2011|50The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells|Cells|2024|2